Crossmark

Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction

Crossref DOI link: https://doi.org/10.1038/nm.4328

Published Online: 2017-04-24

Published Print: 2017-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Qi, Weier

Keenan, Hillary A

Li, Qian

Ishikado, Atsushi

Kannt, Aimo

Sadowski, Thorsten

Yorek, Mark A

Wu, I-Hsien

Lockhart, Samuel

Coppey, Lawrence J

Pfenninger, Anja

Liew, Chong Wee https://orcid.org/0000-0001-9904-0958
Qiang, Guifen

Burkart, Alison M

Hastings, Stephanie

Pober, David

Cahill, Christopher

Niewczas, Monika A https://orcid.org/0000-0003-2371-595X
Israelsen, William J

Tinsley, Liane

Stillman, Isaac E

Amenta, Peter S

Feener, Edward P

Vander Heiden, Matthew G

Stanton, Robert C

King, George L
License Information

Text and Data Mining valid from 2017-04-24
More Information

Article History

Received: 22 January 2017

Accepted: 23 March 2017

First Online: 24 April 2017

Competing interests

: A.K., T.S. and A.P. are employees of Sanofi-Aventis.